Liu Yandong: we hope Xinda will make further efforts to provide people with effective and low-cost biological drugs as soon as possible

Source: Xinda biology 2016-06-30 new drug research and development is the strategic commanding point of international science and technology and economic competition, and innovation mode is the core of commanding technology, brand, capital resources and promoting enterprise development Therefore, the state attaches great importance to the research and development of new drugs, and frequently launches the surging pharmaceutical policy reform, which has experienced many tests Some independent innovation pharmaceutical enterprises stand out and sing the inspiring "good voice of China" Xinda biopharmaceutical (Suzhou) Co., Ltd has become one of the super strength "singers" with its outstanding innovation ability and unique development mode Since its establishment, Xinda biology has been based on the independent innovation and development strategy, committed to "being the best high-end biopharmaceutical pharmaceutical company in China and the first-class in the world, developing high-quality biopharmaceuticals affordable to the common people", and has made remarkable achievements, becoming the leader of the industry, not only attracting the attention of the industry, but also attracting the high-level leaders of the government at all levels to stop and investigate On the afternoon of June 20, 2016, Liu Yandong, a member of the Political Bureau of the Central Committee, vice premier of the State Council and member of the Party group, and his delegation visited Xinda biopharmaceutical (Suzhou) Co., Ltd and gave guidance Liu Yandong said: "Xinda has developed rapidly, and the product chain of independent innovation Biopharmaceutics is very rich I hope Xinda can make further efforts, develop faster in the future, and provide a large number of Biopharmaceutics with good efficacy and low cost for the people as soon as possible." Liu Yandong's visit and care is another recognition and praise for Xinda's achievements; Liu Yandong's ardent instructions will also become a strong driving force for Xinda's further leapfrog development Dr Yu Dechao, chairman of Xinda biopharmaceutical company, warmly reported the development of Xinda biopharmaceutical since its establishment to Liu Yandong, introduced the development status of domestic and foreign biopharmaceutical industry, and pointed out that the main reasons for the backwardness of domestic biopharmaceutical industry are the poor ability of independent innovation, the product quality failing to meet the international standards and the small scale of industrialization, while Xinda biopharmaceutical has established a With a rich and high-quality product chain, it has built the largest industrial base in China, which conforms to international standards, and built an internationally first-class and experienced R & D team, which is expected to change China's backward appearance Dr Yu also reported to Liu Yandong the two comprehensive strategic cooperation with us $3.3 billion between Cinda and US Lilly group, an international pharmaceutical giant, as well as the fact that as a representative of China's outstanding innovative enterprises, he participated in the "Sixth China US innovation dialogue" held at the invitation of the State Council During the inspection, Liu Yandong also listened to Dr Yu's introduction to the production process and process of Xinda da da da da da da During the investigation, Liu Yandong nodded his approval frequently for the achievements in the development of Cinda, and raised several expectations for the development of Cinda and biomedical industry from a high position Liu Yandong pointed out that there are a large number of cancer patients in China at present, and the government is promoting the linkage of "medical treatment", "medical insurance" and "medicine", but "medicine" is a short board, and the drugs with good disease treatment effect are very scarce; moreover, many domestic pharmaceutical enterprises lack credibility, and a large number of enterprises' drugs have been withdrawn or automatically withdrawn in the self-examination and verification of drug clinical test data launched by the drug administration Liu Yandong believes that Xinda biology, with the development concept of "starting with faith, achieving in practice", has grown rapidly in more than four years, and has made many outstanding achievements, which is worth learning from the industry He hopes that other enterprises, like Xinda, will aim at the forefront and adhere to independent innovation; improve the level of research and development and production, strengthen international cooperation, so as to let Chinese bio pharmaceuticals go abroad; pay attention to intellectual property Rights and patents benefit more people At the same time, Liu Yandong pointed out to the leaders of Jiangsu provincial Party committee that he would like to speed up the review and approval of biopharmaceuticals, shorten the detention time and decentralize the power properly He hoped that Jiangsu Province would develop into a strong province of national medicine, support such excellent pharmaceutical enterprises as Xinda, and really let the people use high-efficiency drugs with good quality and low price Luo Zhijun, Secretary of Jiangsu provincial Party committee and director of the Standing Committee of the provincial people's Congress, Zhou Naixiang, Secretary of Suzhou municipal Party committee, Yang Zhiping, deputy secretary of the Party Working Committee and director of the Management Committee of Suzhou Industrial Park and other relevant leaders accompanied the inspection